Dedicated to bringing hope to underserved patients.

Inspired by the bravery of rare disease patients and their support networks, we are relentlessly pursuing the development and delivery of impactful therapeutic solutions.

Our Dedicated Team

EXCUTIVE OFFICERS

Dr. Michael Myers

Co Founder, Chairman, Chief
Executive Officer and Director

Denise Carter

Co Founder, Chief Operating
Officer and Director

Gordon Dunn

Chief Financial Officer

BOARD OF DIRECTORS

Michael Sember

Director

SCIENTIFIC ADVISORS

Dr. Amy Paller
Professor Alan Irvine
Professor Jemima Mellerio

Our Global Partners:

A Message from the CEO

At Quoin, we understand that rare diseases are only rare if you don’t live with one. While researchers have made significant progress in diagnosing, treating and even preventing many rare diseases, the vast majority still lack effective therapeutic drug products.

Our mission could not be clearer; we want to bring hope where there is currently none. We are targeting neglected and underserved patient populations who face a daily reality of limited or no treatment options.

We strive every day to advance our product pipeline, our distribution channels and our commercialization capabilities to ensure we are positioned to reach every single patient who could benefit from our products.

To the neglected rare disease community, we have a very simple message. We will not stop our efforts until we succeed.

All the best,
Dr. Michael Myers, CEO

Rare diseases are only rare if you don’t live with one.®

Subscribe to Email Alerts

Sign up for alerts to stay up to date on Quoin Pharmaceuticals.

Latest News: